Clinical Trial Update: Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether selenium can prevent recurrence of bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: KU Leuven | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED